5.0
Dec 18, 2024
Current employee, more than 1 year
Recommend
CEO approval
Business outlook
Pros
- Excellent benefits - Remote working model - Dynamic environment with exciting products and pipeline
Cons
- Fast-paced could be difficult for those coming from Big Pharma - Organizational changes mean adaptation needed frequently